GlassScriptPhysician profile
Stephen C Dobratz
NPI 1023011194
$9,596.02
in general payments reported to CMS, 2019-2025
22 companies · $584 in 2025
The $584 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,497 · 2020: $331 · 2021: $679 · 2022: $1,209 · 2023: $1,630 · 2024: $666 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,105 · Travel and Lodging: $775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,105.25 |
| Travel and Lodging | $774.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,321.50 | 2021-2025 | Linq II, Hawkone, Aurora Ev-Icd Mri Surescan |
| Abiomed | $2,597.33 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $1,447.16 | 2019-2020 | |
| Cardiovascular Systems INC. | $609.76 | 2019 | |
| Philips North America LLC | $426.93 | 2019-2023 | |
| Astellas Pharma US INC | $198.00 | 2019 | |
| Shockwave Medical, INC | $186.63 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $143.50 | 2021-2025 | Supera |
| Novartis Pharmaceuticals Corporation | $140.08 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $138.97 | 2019-2025 | Lifevest |
| Imperative Care, INC | $79.24 | 2024-2025 | Prodigy Catheter |
| Boston Scientific Corporation | $74.71 | 2019-2023 | Eluvia |
| Silk Road Medical, INC. | $64.88 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Livanova USA, INC. | $24.99 | 2022 | |
| Kestra Medical Technology Services, INC. | $21.18 | 2024 | Assure Wcd |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cagent Vascular INC | $20.34 | 2025 | Serrantor |
| Bardy Diagnostics, INC. | $20.00 | 2021 | |
| Amgen INC. | $19.57 | 2019 | |
| Lantheus Medical Imaging, INC. | $17.65 | 2019 | |
| Irhythm Technologies, INC. | $15.43 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.20 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Dobratz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.